The median concentration of MIF in gastric cancer patients’ serum was 1933 pg ml−1 compared with 414 pg ml−1 for the non-cancer controls (P=1.84 × 10−7, Wilcoxon's test) (Figure 5D). This evidence concerns the gene MIF and gastric cancer.